196 related articles for article (PubMed ID: 19590060)
1. A large family with a gain-of-function mutation of complement C3 predisposing to atypical hemolytic uremic syndrome, microhematuria, hypertension and chronic renal failure.
Lhotta K; Janecke AR; Scheiring J; Petzlberger B; Giner T; Fally V; Würzner R; Zimmerhackl LB; Mayer G; Fremeaux-Bacchi V
Clin J Am Soc Nephrol; 2009 Aug; 4(8):1356-62. PubMed ID: 19590060
[TBL] [Abstract][Full Text] [Related]
2. Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome.
Frémeaux-Bacchi V; Miller EC; Liszewski MK; Strain L; Blouin J; Brown AL; Moghal N; Kaplan BS; Weiss RA; Lhotta K; Kapur G; Mattoo T; Nivet H; Wong W; Gie S; Hurault de Ligny B; Fischbach M; Gupta R; Hauhart R; Meunier V; Loirat C; Dragon-Durey MA; Fridman WH; Janssen BJ; Goodship TH; Atkinson JP
Blood; 2008 Dec; 112(13):4948-52. PubMed ID: 18796626
[TBL] [Abstract][Full Text] [Related]
3. Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.
Bresin E; Rurali E; Caprioli J; Sanchez-Corral P; Fremeaux-Bacchi V; Rodriguez de Cordoba S; Pinto S; Goodship TH; Alberti M; Ribes D; Valoti E; Remuzzi G; Noris M;
J Am Soc Nephrol; 2013 Feb; 24(3):475-86. PubMed ID: 23431077
[TBL] [Abstract][Full Text] [Related]
4. A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function.
Roumenina LT; Frimat M; Miller EC; Provot F; Dragon-Durey MA; Bordereau P; Bigot S; Hue C; Satchell SC; Mathieson PW; Mousson C; Noel C; Sautes-Fridman C; Halbwachs-Mecarelli L; Atkinson JP; Lionet A; Fremeaux-Bacchi V
Blood; 2012 May; 119(18):4182-91. PubMed ID: 22246034
[TBL] [Abstract][Full Text] [Related]
5. [Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].
Frémeaux-Bacchi V; Fakhouri F; Roumenina L; Dragon-Durey MA; Loirat C
Rev Med Interne; 2011 Apr; 32(4):232-40. PubMed ID: 21376430
[TBL] [Abstract][Full Text] [Related]
6. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype.
Noris M; Caprioli J; Bresin E; Mossali C; Pianetti G; Gamba S; Daina E; Fenili C; Castelletti F; Sorosina A; Piras R; Donadelli R; Maranta R; van der Meer I; Conway EM; Zipfel PF; Goodship TH; Remuzzi G
Clin J Am Soc Nephrol; 2010 Oct; 5(10):1844-59. PubMed ID: 20595690
[TBL] [Abstract][Full Text] [Related]
7. aHUS associated with C3 gene mutation: a case with numerous relapses and favorable 20-year outcome.
Siomou E; Gkoutsias A; Serbis A; Kollios K; Chaliasos N; Frémeaux-Bacchi V
Pediatr Nephrol; 2016 Mar; 31(3):513-7. PubMed ID: 26572892
[TBL] [Abstract][Full Text] [Related]
8. Novel C3 mutation p.Lys65Gln in aHUS affects complement factor H binding.
Volokhina E; Westra D; Xue X; Gros P; van de Kar N; van den Heuvel L
Pediatr Nephrol; 2012 Sep; 27(9):1519-24. PubMed ID: 22669319
[TBL] [Abstract][Full Text] [Related]
9. Manifestation of atypical hemolytic uremic syndrome caused by novel mutations in MCP.
Provaznikova D; Rittich S; Malina M; Seeman T; Marinov I; Riedl M; Hrachovinova I
Pediatr Nephrol; 2012 Jan; 27(1):73-81. PubMed ID: 21706448
[TBL] [Abstract][Full Text] [Related]
10. The molecular and structural bases for the association of complement C3 mutations with atypical hemolytic uremic syndrome.
Martínez-Barricarte R; Heurich M; López-Perrote A; Tortajada A; Pinto S; López-Trascasa M; Sánchez-Corral P; Morgan BP; Llorca O; Harris CL; Rodríguez de Córdoba S
Mol Immunol; 2015 Aug; 66(2):263-73. PubMed ID: 25879158
[TBL] [Abstract][Full Text] [Related]
11. Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome.
Fang CJ; Fremeaux-Bacchi V; Liszewski MK; Pianetti G; Noris M; Goodship TH; Atkinson JP
Blood; 2008 Jan; 111(2):624-32. PubMed ID: 17914026
[TBL] [Abstract][Full Text] [Related]
12. Familial C3 glomerulopathy associated with CFHR5 mutations: clinical characteristics of 91 patients in 16 pedigrees.
Athanasiou Y; Voskarides K; Gale DP; Damianou L; Patsias C; Zavros M; Maxwell PH; Cook HT; Demosthenous P; Hadjisavvas A; Kyriacou K; Zouvani I; Pierides A; Deltas C
Clin J Am Soc Nephrol; 2011 Jun; 6(6):1436-46. PubMed ID: 21566112
[TBL] [Abstract][Full Text] [Related]
13. Analysis of genetic and predisposing factors in Japanese patients with atypical hemolytic uremic syndrome.
Fan X; Yoshida Y; Honda S; Matsumoto M; Sawada Y; Hattori M; Hisanaga S; Hiwa R; Nakamura F; Tomomori M; Miyagawa S; Fujimaru R; Yamada H; Sawai T; Ikeda Y; Iwata N; Uemura O; Matsukuma E; Aizawa Y; Harada H; Wada H; Ishikawa E; Ashida A; Nangaku M; Miyata T; Fujimura Y
Mol Immunol; 2013 Jun; 54(2):238-46. PubMed ID: 23314101
[TBL] [Abstract][Full Text] [Related]
14. Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries.
Neumann HP; Salzmann M; Bohnert-Iwan B; Mannuelian T; Skerka C; Lenk D; Bender BU; Cybulla M; Riegler P; Königsrainer A; Neyer U; Bock A; Widmer U; Male DA; Franke G; Zipfel PF
J Med Genet; 2003 Sep; 40(9):676-81. PubMed ID: 12960213
[TBL] [Abstract][Full Text] [Related]
15. Thrombomodulin mutations in atypical hemolytic-uremic syndrome.
Delvaeye M; Noris M; De Vriese A; Esmon CT; Esmon NL; Ferrell G; Del-Favero J; Plaisance S; Claes B; Lambrechts D; Zoja C; Remuzzi G; Conway EM
N Engl J Med; 2009 Jul; 361(4):345-57. PubMed ID: 19625716
[TBL] [Abstract][Full Text] [Related]
16. Genetics and complement in atypical HUS.
Kavanagh D; Goodship T
Pediatr Nephrol; 2010 Dec; 25(12):2431-42. PubMed ID: 20526633
[TBL] [Abstract][Full Text] [Related]
17. Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome.
Maga TK; Nishimura CJ; Weaver AE; Frees KL; Smith RJ
Hum Mutat; 2010 Jun; 31(6):E1445-60. PubMed ID: 20513133
[TBL] [Abstract][Full Text] [Related]
18. Tailored eculizumab therapy in the management of complement factor H-mediated atypical hemolytic uremic syndrome in an adult kidney transplant recipient: a case report.
Xie L; Nester CM; Reed AI; Zhang Y; Smith RJ; Thomas CP
Transplant Proc; 2012 Dec; 44(10):3037-40. PubMed ID: 23195022
[TBL] [Abstract][Full Text] [Related]
19. Genetic analysis and functional characterization of novel mutations in a series of patients with atypical hemolytic uremic syndrome.
Szarvas N; Szilágyi Á; Csuka D; Takács B; Rusai K; Müller T; Arbeiter K; Réti M; Haris Á; Wagner L; Török S; Kelen K; Szabó AJ; Reusz GS; Morgan BP; Prohászka Z
Mol Immunol; 2016 Mar; 71():10-22. PubMed ID: 26826462
[TBL] [Abstract][Full Text] [Related]
20. The Relevance of the MCP Risk Polymorphism to the Outcome of aHUS Associated With C3 Mutations. A Case Report.
Lumbreras J; Subias M; Espinosa N; Ferrer JM; Arjona E; Rodríguez de Córdoba S
Front Immunol; 2020; 11():1348. PubMed ID: 32765494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
